Ho Tung Chemical Corp. (1714.TW)
New Taipei City, TW
Ho Tung Chemical Corp., established in New Taipei City, Taiwan, in 1980, operates as a comprehensive chemical enterprise. The company specializes in the research, production, marketing, and global distribution of a diverse array of chemical products, with a significant presence across Taiwan, China, Southeast Asia, and other international markets. Its core product portfolio encompasses a wide range of specialty chemicals. Key offerings include normal paraffin and various types of surfactants essential for industries like detergents and personal care. Specifically, it manufactures anionic surfactants such as linear alkylbenzene sulphonic acid (LABSA) and alcohol ether sulfates (e.g., sodium laureth sulphate); cationic surfactants like palmityl tri-methyl ammonium chloride, stearyl tri-methyl ammonium chloride, and alkyl dimethyl benzyl ammonium chloride; and non-ionic surfactants, including fatty alcohols, fatty alcohol ethoxylates, and coconut diethanol amide. Additionally, the company produces amphoteric surfactants such as cocamidopropyl betaine and dodecyl dimethyl betaine. Ho Tung also supplies de-aromatic solvents, which find application in diverse sectors including paints, coatings, consumer products, printing inks, and agricultural chemicals. Beyond its primary chemical manufacturing, Ho Tung diversifies its operations through various ventures. These include the trading and wholesale of oil, fuels, and other general commodities; the leasing of oil storage facilities; and the production and sale of cement, cement raw materials, and PMMA light guide plates. The company is also involved in the development of new energy solutions and advanced surfactants, alongside general investment activities.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.49% | +11.29% | +0.49% | +10.10% | +21.59% | +26.86% | +20.45% | +12.89% | +0.00% | +64.53% | +89.11% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+16.5% ★ Q1'26: +33.4% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+22.0% ★ Q1'26: +187.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+2.0% Q1'26: +6.9% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+5.2% Q1'26: +6.9% (vs Q1'25)
-
ROIC Chemicals: +3.4%+8.3% ★ Q1'26: +13.1% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+138.1% Q1'26: +68.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×1.78× ★ Q1'26: 1.62× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2011 actual |
|---|---|
| Revenue |
47.47B
est: 13.52B (+251.0%)
|
| EBITDA |
3.09B
est: 1.34B (+131.0%)
|
| EBIT |
2.55B
est: 990.64M (+157.5%)
|
| Net Income |
1.17B
|
| SGA |
1.36B
est: 768.59M (+77.6%)
|
| EPS |
1.16
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.04% | 316.1K | 0.65% |
| 2 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.04% | 42.5K | 0.42% |
| 3 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.01% | 23.1K | 0.33% |
| 4 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.01% | 19.3K | 0.35% |
| 5 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 782.5K | 0.06% |
| 6 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 24.8K | 0.48% |
| 7 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 55.9K | 0.26% |
| 8 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 2.76M | 0.06% |
| 9 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 424.6K | 0.33% |
| 10 | Vanguard ESG International Stock ETF VSGX | 0.00% | 88.8K | 0.10% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yi-Ju Chen | GM & Director | 11M | female |
| Rongping Bo | Legal Director | 4M | female |
| Ying-Yen Li | Financial Supervisor | 3M | male |
| Hui-Yen Lin | Accounting Supervisor | 3M | — |
| Chieh Chu Pai | Chief Information Security Officer | — | — |
| Zhen-Bin Zheng | Chief Corporate Governance Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1714.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
